Some pleiotropic effects of statins on hepatocellular carcinoma cells: Comparative study on atorvastatin, rosuvastatin and simvastatin
- 19 July 2023
- journal article
- research article
- Published by Elsevier in Advances in Medical Sciences
- Vol. 68 (2) , 258-264
Abstract
No abstract availableKeywords
Funding Information
- Federalno Ministarstvo Obrazovanja i Nauke (05-35-3210-1/21)
This publication has 43 references indexed in Scilit:
- Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and RosuvastatinAnnals of Clinical Microbiology and Antimicrobials, 2012
- Differential Effects of Pravastatin and Simvastatin on the Growth of Tumor Cells from Different Organ SitesPLOS ONE, 2011
- Simvastatin inhibits cell growth and induces apoptosis and G0/G1 cell cycle arrest in hepatic cancer cellsInternational Journal of Molecular Medicine, 2010
- Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-AnalysisDiabetes Care, 2009
- Statin-Induced Inhibition of MCF-7 Breast Cancer Cell Proliferation is Related to Cell Cycle Arrest and Apoptotic and Necrotic Cell Death Mediated by an Enhanced Oxidative StressCancer Investigation, 2008
- Differences in antitumor effects of various statins on human pancreatic cancerInternational Journal of Cancer, 2007
- PLEIOTROPIC EFFECTS OF STATINSAnnual Review of Pharmacology and Toxicology, 2005
- Uptake of rosuvastatin by isolated rat hepatocytes: comparison with pravastatinXenobiotica, 2003
- Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitor11CRESTOR is a trademark, the property of AstraZeneca PLC. Research discussed in this article was supported by AstraZeneca.The American Journal of Cardiology, 2001
- Regulation of the mevalonate pathwayNature, 1990